Skip to contentA
Axim Biotechnologies, Inc.
A
AXIMAxim Biotechnologies, Inc. Q2 2020 · 10-Q
Revenue$0.00$0.00no prior Q2 2019 on file Net Income-$79.39K-$79.39KN/M vs Q2 2019 EPS Diluted$0.00$0.00N/M vs Q2 2019 Operating Income-$662,862— Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Axim Biotechnologies, Inc. · CIK 1514946 · Engraved from SEC EDGAR
derived
ended Jun 30, 2020 · filed Aug 14, 2020 · 45 d after period end